Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 230-907-9 | CAS number: 7365-45-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Sep 24, 2002 - Feb 27-2003
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 003
- Report date:
- 2003
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 21 July 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- 19 May 2000
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- Version / remarks:
- 11 September 1989
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 4-(2-hydroxyethyl)piperazin-1-ylethanesulphonic acid
- EC Number:
- 230-907-9
- EC Name:
- 4-(2-hydroxyethyl)piperazin-1-ylethanesulphonic acid
- Cas Number:
- 7365-45-9
- Molecular formula:
- C8H18N2O4S
- IUPAC Name:
- 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid
Constituent 1
Method
- Target gene:
- His operon (Salmonella), Trp operon (E. coli)
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- Due to migration, the value was transferred to one of the current document's attachments
- Test concentrations with justification for top dose:
- 1st series: 5.00, 15.8, 50.0, 158, 500, 1580 and 5000 µg per plate (with and without S9 mix)
2nd series: 50.0, 158, 500, 1580 and 5000 µg per plate (with and without S9 mix) - Vehicle / solvent:
- - Vehicle used: aqueous solvents (bidest. water)
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- DAUN
- Positive control substance:
- other: Daunomycin
- Remarks:
- without S9 mix (TA 98)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- CUM
- Positive control substance:
- cumene hydroperoxide
- Remarks:
- without S9 mix (TA 102)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 9-AA
- Positive control substance:
- 9-aminoacridine
- Remarks:
- without S9 mix (TA 1537)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- ENNG
- Positive control substance:
- N-ethyl-N-nitro-N-nitrosoguanidine
- Remarks:
- without S9 mix (TA 100, TA 1535, WP 2 uvrA)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- B(a)P
- Positive control substance:
- benzo(a)pyrene
- Remarks:
- with S9 mix (TA 102)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- 2-AA
- Positive control substance:
- other: 2-aminoanthracene
- Remarks:
- with S9 mix (TA 98, TA 100, TA 1535, TA 1537, WP 2 uvrA)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Preincubation period: no
- Exposure duration: 48 - 52 hours
NUMBER OF REPLICATIONS: 3
DETERMINATION OF CYTOTOXICITY
- Method: background clearance - Evaluation criteria:
- A test material is defined as non-mutagenic in this assay if
- "no" or "weak increases" occur in the first and second series of the main experiment. ("Weak increases" randomly occur due to experimental variation.)
A test material is defined as mutagenic in this assay if
- a dose-related (over at least two test material concentrations) increase in the number of revertants is induced, the maximal effect is a "clear increase", and the effects are reproduced at similar concentration levels in the same test system;
- "clear increases" occur at least at one test material concentration, higher concentrations show strong precipitation or cytotoxicity, and the effects are reproduced at the same concentration level in the same test system. - Statistics:
- no
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
No confounding factors observed.
STUDY RESULTS
- Concurrent vehicle negative and positive control data : Refer to "Any other information on results incl. tables"
- For all test methods and criteria for data analysis and interpretation: Refer to "Any other information on materials and methods incl. tables"
- Signs of toxicity : No cytotoxicity was observed.
- Mean number of revertant colonies per plate and standard deviation : Refer to "Any other information on results incl. tables"
HISTORICAL CONTROL DATA
- Negative (solvent/vehicle) historical control data:
According to the publications of Levin et al. (1982) and Kier et al. (1986) and the historical controls of the laboratory, usually the following mean numbers of revertants are acceptable as negative (or solvent) controls for the bacterial strains used:
TA 98: 15 - 60
TA 1535: 3 - 37
TA 100: 75 -200
TA 1537: 4 - 31
TA 102: 200-450
WP2 uvrA: 10-70
Any other information on results incl. tables
Table 2 Mean Number of Revertant Colonies
Series 1 (10 % S9 mix) | ||||||||||||
Dose (µg/plate) | Mean number of revertant colonies/3 replicate plates with different strains of Salmonella typhimurium | |||||||||||
TA1535 | SD | TA1537 | SD | TA98 | SD | TA100 | SD | TA102 | SD | WP2 uvrA | SD | |
Results with S9 | ||||||||||||
Solvent |
22 | 4 | 8 | 3 | 30 | 3 | 14 | 14 | 401 | 18 | 36 | 10 |
5 | 16 | 4 | 6 | 4 | 29 | 6 | 24 | 24 | 346 | 18 | 30 | 3 |
15.8 |
16 | 4 | 13 | 3 | 28 | 6 | 8 | 8 | 340 | 9 | 36 | 1 |
50 | 21 | 12 | 9 | 3 | 28 | 2 | 12 | 12 | 309 | 17 | 33 | 5 |
158 | 16 | 5 | 7 | 1 | 24 | 1 | 8 | 8 | 384 | 12 | 42 | 6 |
500 | 17 | 4 | 8 | 3 | 28 | 7 | 16 | 16 | 362 | 18 | 45 | 2 |
1580 | 20 | 6 | 9 | 2 | 30 | 11 | 20 | 20 | 407 | 19 | 44 | 7 |
5000 | 20 | 4 | 10 | 5 | 33 | 16 | 16 | 16 | 352 | 15 | 38 | 7 |
Results without S9 | ||||||||||||
Solvent |
18 | 3 | 10 | 4 | 18 | 4 | 134 | 8 | 341 | 25 | 37 | 10 |
5 | 20 | 7 | 7 | 1 | 21 | 4 | 137 | 12 | 330 | 43 | 33 | 7 |
15.8 | 18 | 9 | 5 | 4 | 20 | 7 | 129 | 6 | 357 | 16 | 38 | 2 |
50 | 15 | 2 | 5 | 1 | 19 | 7 | 127 | 12 | 345 | 18 | 41 | 10 |
158 | 13 | 2 | 8 | 1 | 17 | 4 | 139 | 13 | 363 | 33 | 36 | 8 |
500 | 18 | 3 | 4 | 2 | 17 | 7 | 149 | 19 | 338 | 6 | 42 | 5 |
1580 | 17 | 3 | 4 | 1 | 21 | 5 | 143 | 0 | 340 | 7 | 39 | 1 |
5000 | 17 | 7 | 6 | 5 | 19 | 4 | 149 | 6 | 363 | 21 | 33 | 10 |
Series 2 (30 % S9 mix) | ||||||||||||
Dose (µg/plate) | Mean number of revertant colonies/3 replicate plates with different strains of Salmonella typhimurium | |||||||||||
TA1535 | SD | TA1537 | SD | TA98 | SD | TA100 | SD | TA102 | SD | WP2 uvrA | SD | |
Results with S9 | ||||||||||||
Solvent | 30 | 10 | 13 | 7 | 27 | 5 | 202 | 18 | 377 | 34 | 40 | 7 |
50 | 31 | 5 | 10 | 1 | 25 | 7 | 195 | 15 | 353 | 13 | 43 | 6 |
158 | 26 | 12 | 12 | 4 | 31 | 6 | 203 | 30 | 328 | 35 | 44 | 8 |
500 | 28 | 5 | 12 | 4 | 30 | 2 | 203 | 3 | 361 | 36 | 44 | 6 |
1580 | 30 | 7 | 11 | 1 | 24 | 1 | 194 | 16 | 352 | 26 | 51 | 13 |
5000 | 27 | 8 | 11 | 4 | 26 | 6 | 222 | 3 | 359 | 9 | 34 | 1 |
Results without S9 | ||||||||||||
Solvent | 25 | 2 | 11 | 3 | 19 | 3 | 153 | 11 | 364 | 10 | 38 | 6 |
50 | 32 | 13 | 11 | 2 | 24 | 4 | 169 | 23 | 342 | 54 | 42 | 6 |
158 | 22 | 4 | 11 | 5 | 25 | 12 | 166 | 9 | 376 | 8 | 40 | 9 |
500 | 24 | 4 | 14 | 3 | 17 | 2 | 140 | 21 | 365 | 65 | 41 | 5 |
1580 | 23 | 2 | 10 | 3 | 12 | 3 | 162 | 9 | 360 | 42 | 37 | 6 |
5000 | 22 | 2 | 11 | 1 | 23 | 5 | 157 | 35 | 364 | 40 | 37 | 1 |
Table 3 Positive control results
Strain | Positive control | Conc. [µg/plate] | S9 mix | Mean number of revertant colonies/plate | SD |
TA 98 | DAUN | 4 | - | 677 | 62 |
TA 100 | ENNG | 5 | - | 707 | 17 |
TA 102 | CUM | 200 | - | 1281 | 59 |
TA 1535 | ENNG | 10 | - | 709 | 47 |
TA 1537 | 9-AA | 50 | - | 531 | 75 |
WP 2 uvrA | ENNG | 5 | - | 1308 | 183 |
TA 98 | 2-AA | 2 | + | 500 | 31 |
TA 100 | 2-AA | 2 | + | 517 | 6 |
TA 102 | B(a)p | 10 | + | 1299 | 180 |
TA 1535 | 2-AA | 2 | + | 180 | 33 |
TA 1537 | 2-AA | 5 | + | 211 | 32 |
WP 2 uvrA | 2-AA | 10 | + | 309 | 42 |
Applicant's summary and conclusion
- Conclusions:
- With and without addition of S9 mix as the external metabolizing system, the test item was not mutagenic under the experimental conditions described.
- Executive summary:
This GLP comliant study was performed according to OECD TG 471. The investigations for mutagenic potential were performed using Salmonella typhimurium tester strains TA 98, TA 100, TA 102, TA 1535 and TA 1537, and Escherichia coli WP2 uvrA. The plate incorporation test with and without addition of liver S9 mix from Aroclor 1254-pretreated rats was used. Two independent experimental series were performed. In the two series with S9 mix, 10% and 30% S9 in the S9 mix were used in the 1st and 2nd series, respectively. The test material was dissolved in aqua bidest. and tested at concentrations of 5, 15.8, 50, 158, 500, 1580 and 5000 µg/plate. Precipitation or toxicity of the test material was not observed.
Daunomycin, N-ethyl-N'-nitro-N-nitrosoguanidine, 9 -aminoacridine and cumene hydroperoxide served as strain specific positive control test materials in the absence of S9 mix. 2-Aminoanthracene and benzo[a]pyrene were used for testing the bacteria and the activity of the S9 mix. Each treatment with the test materials used as positive controls led to a clear increase in revertant colonies, thus, showing the expected reversion properties of all strains and good metabolic activity of the S9 mix used.
In both series of experiments, each performed with and without the addition of rat liver S9 mix as the external metabolizing system, the test material showed no increase in the number of revertants of any bacterial strain. With and without addition of S9 mix as the external metabolizing system, the test item was not mutagenic under the experimental conditions described.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
